secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001493152-24-041772
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health receives Nasdaq delisting notice for bid price below $1.00 for 30 consecutive days
--------------------------------------------------------------------------------

- Nasdaq notified Syra Health on Oct 18, 2024 that its common stock bid price closed below $1.00 for 30 business days, violating Listing Rule 5550(a)(2).
- Company has 180 calendar days, until April 16, 2025, to regain compliance by achieving $1.00 closing bid for at least 10 consecutive business days.
- If non-compliance continues, Syra may seek a second 180-day period or appeal a delisting determination to a Nasdaq hearings panel.
- Common stock (SYRA) continues trading on Nasdaq during the cure period; company may consider options such as a reverse stock split.
- No assurance the company will maintain its Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224041772/0001493152-24-041772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224041772/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer